179 related articles for article (PubMed ID: 23529880)
21. Treatment outcomes of patients with primary squamous cell carcinoma of the retromolar trigone.
Rizvi ZH; Alonso JE; Kuan EC; St John MA
Laryngoscope; 2018 Dec; 128(12):2740-2744. PubMed ID: 29756295
[TBL] [Abstract][Full Text] [Related]
22. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
[TBL] [Abstract][Full Text] [Related]
23. Rim versus sagittal mandibulectomy for the treatment of squamous cell carcinoma: two types of mandibular preservation.
Guerra MF; Campo FJ; Gías LN; Pérez JS
Head Neck; 2003 Dec; 25(12):982-9. PubMed ID: 14648856
[TBL] [Abstract][Full Text] [Related]
24. Second salvage surgery for re-recurrent oral cavity and oropharynx carcinoma.
Agra IM; Filho JG; Martins EP; Kowalski LP
Head Neck; 2010 Aug; 32(8):997-1002. PubMed ID: 20191624
[TBL] [Abstract][Full Text] [Related]
25. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.
Been MJ; Watkins J; Manz RM; Gentry LR; Leverson GE; Harari PM; Hartig GK
Laryngoscope; 2008 Aug; 118(8):1377-82. PubMed ID: 18418275
[TBL] [Abstract][Full Text] [Related]
26. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx.
Röösli C; Tschudi DC; Studer G; Braun J; Stoeckli SJ
Laryngoscope; 2009 Mar; 119(3):534-40. PubMed ID: 19235752
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
28. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.
Pericot J; Escribà JM; Valdés A; Biosca MJ; Monner A; Castellsagué X; Galiana R; Piulachs P; Escutia E; Mari A
J Craniomaxillofac Surg; 2000 Feb; 28(1):49-55. PubMed ID: 10851674
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.
Agra IM; Carvalho AL; Ulbrich FS; de Campos OD; Martins EP; Magrin J; Kowalski LP
Head Neck; 2006 Feb; 28(2):107-13. PubMed ID: 16388526
[TBL] [Abstract][Full Text] [Related]
30. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.
Rusthoven K; Ballonoff A; Raben D; Chen C
Cancer; 2008 Jan; 112(2):345-51. PubMed ID: 18041071
[TBL] [Abstract][Full Text] [Related]
31. Nodal yield in neck dissection and the likelihood of metastases.
Agrama MT; Reiter D; Cunnane MF; Topham A; Keane WM
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):185-90. PubMed ID: 12601312
[TBL] [Abstract][Full Text] [Related]
32. Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx.
De Stefani A; Forni G; Ragona R; Cavallo G; Bussi M; Usai A; Badellino F; Cortesina G
Cancer; 2002 Jul; 95(1):90-7. PubMed ID: 12115321
[TBL] [Abstract][Full Text] [Related]
33. Is the new TNM (1997) the best system for predicting prognosis?
Carinci F; Farina A; Longhini L; Urso RG; Pelucchi S; Calearo C
Int J Oral Maxillofac Surg; 1999 Jun; 28(3):203-5. PubMed ID: 10355943
[TBL] [Abstract][Full Text] [Related]
34. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
Sklenicka S; Gardiner S; Dierks EJ; Potter BE; Bell RB
J Oral Maxillofac Surg; 2010 Jun; 68(6):1270-5. PubMed ID: 20347201
[TBL] [Abstract][Full Text] [Related]
35. Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.
Sowder JC; Cannon RB; Buchmann LO; Hunt JP; Hitchcock Y; Lloyd S; Grossmann KF; Monroe MM
Head Neck; 2017 May; 39(5):876-880. PubMed ID: 28236368
[TBL] [Abstract][Full Text] [Related]
36. [The ASA-score as a comorbidity index in patients with cancer of the oral cavity and oropharynx].
Riechelmann H; Neagos A; Netzer-Yilmaz U; Gronau S; Scheithauer M; Rockemann MG
Laryngorhinootologie; 2006 Feb; 85(2):99-104. PubMed ID: 16498538
[TBL] [Abstract][Full Text] [Related]
37. The prognostic and staging implications of bone invasion in oral squamous cell carcinoma.
Ebrahimi A; Murali R; Gao K; Elliott MS; Clark JR
Cancer; 2011 Oct; 117(19):4460-7. PubMed ID: 21437887
[TBL] [Abstract][Full Text] [Related]
38. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
39. Influence of close resection margins on local recurrence and disease-specific survival in oral and oropharyngeal carcinoma.
Wong LS; McMahon J; Devine J; McLellan D; Thompson E; Farrow A; Moos K; Ayoub A
Br J Oral Maxillofac Surg; 2012 Mar; 50(2):102-8. PubMed ID: 21742422
[TBL] [Abstract][Full Text] [Related]
40. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
